Biopharma

Identify the concentration, size, and types of subvisible and submicron particles present in biopharmaceutical formulations, including protein, cell, and gene therapies with flow imaging microscopy as recommended by USP <1788>.

Gain insight into the sources of particles in biological drug products and optimize formulations and manufacturing processes to minimize and control particle formation and ensure that USP <787> and <788> particle requirements are met.

Stock illustration of antibodies floating

Protein Therapeutics

Stay ahead of protein aggregation during formulation. Detect and control particulates and potential contaminants during manufacturing by monitoring changes in particle size distributions, concentrations, and particle types.

Learn more

Cell and Gene Therapy

Preemptively control particles in your cell and gene therapy drug products. Use particle analytics to assess cell concentrations and viability, detect viral and non-viral vector aggregation, and design formulations and processes to maximize your drug product’s stability.

Learn more

Stock photo of biotherapeutic vial and syringe

Other Therapeutics

Measure and control particles in formulations of biotherapeutics and drug delivery systems throughout the manufacturing process from the bioreactor to point-of-care.

Learn more